Biomarker Discovery is a process in which molecular substances in the body are used to indicate health or disease. One of the biggest challenges in biomarker discovery is the difficulty of identifying medium to low abundance proteins in complex biological samples.
-
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi...
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i...
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
OCT 30, 2024 | 8:00 AM
C.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w...
The human antibody repertoire, or reactome, is a vast and dynamic network of antibody-antigen interactions that plays a crucial role in health and disease. Understanding the complexity of th...
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by malignant T-cell skin infiltration leading to inflammation and skin barrier defects. To effecti...
Metabolomics research involves two approaches: untargeted analysis, which provides a broad overview of molecular changes but lacks precision, and targeted analysis, which focuses on specific...
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
The field of proteomics is undergoing a revolution to better quantify proteins and unlock the dynamic and valuable source of functional biological insight held in the proteome. Single-molecu...
The advancement in ultra-sensitive immunoassays and highly specific immunoprecipitation mass spectrometry (IPMS) methods, complimented by an increasing number of well-characterised research...
FEB 21, 2024 | 7:30 AM
C.E. CREDITS
Multiplex immunofluorescence is a powerful tool for phenotyping cells from a single tissue slide, while preserving spatial context. The MultiOmyxTM platform, offered as an end to end service...
The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can&rsquo...
Proliferation biomarkers are proteins that are up-regulated in growing cells. Immunological staining of tumor tissue can provide an indication of the aggressivity of the tumor and provide in...
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
Extracellular vesicles (EVs) are lipid-bilayer enclosed nano-sized vesicles that are released by all cell types and found in all bodily fluids. EVs are emerging as important regulators of bo...